nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitomycin—stomach cancer—colon cancer	0.639	1	CtDrD
Mitomycin—ABCB1—colon cancer	0.287	1	CbGaD
Mitomycin—ABCB1—Irinotecan—colon cancer	0.0123	0.416	CbGbCtD
Mitomycin—ABCB1—Vincristine—colon cancer	0.0107	0.364	CbGbCtD
Mitomycin—ABCB1—Methotrexate—colon cancer	0.0065	0.22	CbGbCtD
Mitomycin—Cardiotoxicity—Fluorouracil—colon cancer	0.00245	0.055	CcSEcCtD
Mitomycin—Dry cough—Methotrexate—colon cancer	0.00194	0.0436	CcSEcCtD
Mitomycin—Pulmonary toxicity—Methotrexate—colon cancer	0.00132	0.0297	CcSEcCtD
Mitomycin—Myelosuppression—Vincristine—colon cancer	0.00132	0.0296	CcSEcCtD
Mitomycin—Lung infiltration—Irinotecan—colon cancer	0.00128	0.0288	CcSEcCtD
Mitomycin—Myelosuppression—Fluorouracil—colon cancer	0.00123	0.0276	CcSEcCtD
Mitomycin—Necrosis—Fluorouracil—colon cancer	0.000735	0.0165	CcSEcCtD
Mitomycin—Stinging—Fluorouracil—colon cancer	0.000712	0.016	CcSEcCtD
Mitomycin—Extravasation—Vincristine—colon cancer	0.000709	0.0159	CcSEcCtD
Mitomycin—Extravasation—Irinotecan—colon cancer	0.00069	0.0155	CcSEcCtD
Mitomycin—Extravasation—Fluorouracil—colon cancer	0.000661	0.0148	CcSEcCtD
Mitomycin—Lung infiltration—Methotrexate—colon cancer	0.00064	0.0144	CcSEcCtD
Mitomycin—Ulcer—Irinotecan—colon cancer	0.000637	0.0143	CcSEcCtD
Mitomycin—Ulcer—Fluorouracil—colon cancer	0.00061	0.0137	CcSEcCtD
Mitomycin—Haematemesis—Capecitabine—colon cancer	0.00058	0.013	CcSEcCtD
Mitomycin—Thrombophlebitis—Irinotecan—colon cancer	0.000505	0.0113	CcSEcCtD
Mitomycin—Thrombophlebitis—Fluorouracil—colon cancer	0.000484	0.0109	CcSEcCtD
Mitomycin—Renal impairment—Irinotecan—colon cancer	0.000459	0.0103	CcSEcCtD
Mitomycin—Haematemesis—Methotrexate—colon cancer	0.000432	0.0097	CcSEcCtD
Mitomycin—Burning sensation—Methotrexate—colon cancer	0.000432	0.0097	CcSEcCtD
Mitomycin—Ulcer—Capecitabine—colon cancer	0.000426	0.00957	CcSEcCtD
Mitomycin—Injection site reaction—Capecitabine—colon cancer	0.000401	0.009	CcSEcCtD
Mitomycin—Necrosis—Methotrexate—colon cancer	0.000382	0.00859	CcSEcCtD
Mitomycin—Pancytopenia—Vincristine—colon cancer	0.000368	0.00828	CcSEcCtD
Mitomycin—Extravasation—Methotrexate—colon cancer	0.000344	0.00772	CcSEcCtD
Mitomycin—Pancytopenia—Fluorouracil—colon cancer	0.000344	0.00772	CcSEcCtD
Mitomycin—Thrombophlebitis—Capecitabine—colon cancer	0.000338	0.00759	CcSEcCtD
Mitomycin—Stomatitis—Vincristine—colon cancer	0.000337	0.00757	CcSEcCtD
Mitomycin—Renal failure—Irinotecan—colon cancer	0.000331	0.00744	CcSEcCtD
Mitomycin—Stomatitis—Irinotecan—colon cancer	0.000328	0.00738	CcSEcCtD
Mitomycin—Ulcer—Methotrexate—colon cancer	0.000317	0.00713	CcSEcCtD
Mitomycin—Stomatitis—Fluorouracil—colon cancer	0.000315	0.00706	CcSEcCtD
Mitomycin—Renal impairment—Capecitabine—colon cancer	0.000307	0.00691	CcSEcCtD
Mitomycin—Alopecia—Vincristine—colon cancer	0.000274	0.00616	CcSEcCtD
Mitomycin—Alopecia—Irinotecan—colon cancer	0.000267	0.006	CcSEcCtD
Mitomycin—Pulmonary oedema—Methotrexate—colon cancer	0.000267	0.006	CcSEcCtD
Mitomycin—Alopecia—Fluorouracil—colon cancer	0.000256	0.00575	CcSEcCtD
Mitomycin—Erythema—Fluorouracil—colon cancer	0.000252	0.00566	CcSEcCtD
Mitomycin—Thrombophlebitis—Methotrexate—colon cancer	0.000252	0.00565	CcSEcCtD
Mitomycin—Anaemia—Vincristine—colon cancer	0.00025	0.00561	CcSEcCtD
Mitomycin—Ill-defined disorder—Irinotecan—colon cancer	0.000244	0.00549	CcSEcCtD
Mitomycin—Anaemia—Irinotecan—colon cancer	0.000243	0.00547	CcSEcCtD
Mitomycin—Leukopenia—Vincristine—colon cancer	0.000242	0.00544	CcSEcCtD
Mitomycin—Pancytopenia—Capecitabine—colon cancer	0.00024	0.00539	CcSEcCtD
Mitomycin—Vision blurred—Fluorouracil—colon cancer	0.000238	0.00534	CcSEcCtD
Mitomycin—Malaise—Irinotecan—colon cancer	0.000237	0.00533	CcSEcCtD
Mitomycin—Syncope—Irinotecan—colon cancer	0.000236	0.0053	CcSEcCtD
Mitomycin—Leukopenia—Irinotecan—colon cancer	0.000236	0.00529	CcSEcCtD
Mitomycin—Hypertension—Vincristine—colon cancer	0.000233	0.00524	CcSEcCtD
Mitomycin—Anaemia—Fluorouracil—colon cancer	0.000233	0.00523	CcSEcCtD
Mitomycin—Loss of consciousness—Irinotecan—colon cancer	0.000231	0.0052	CcSEcCtD
Mitomycin—Cough—Irinotecan—colon cancer	0.00023	0.00516	CcSEcCtD
Mitomycin—Hypertension—Irinotecan—colon cancer	0.000227	0.00511	CcSEcCtD
Mitomycin—Leukopenia—Fluorouracil—colon cancer	0.000226	0.00507	CcSEcCtD
Mitomycin—Renal failure—Capecitabine—colon cancer	0.000222	0.00498	CcSEcCtD
Mitomycin—Discomfort—Irinotecan—colon cancer	0.000221	0.00497	CcSEcCtD
Mitomycin—Oedema—Vincristine—colon cancer	0.000221	0.00496	CcSEcCtD
Mitomycin—Stomatitis—Capecitabine—colon cancer	0.00022	0.00494	CcSEcCtD
Mitomycin—Confusional state—Irinotecan—colon cancer	0.000217	0.00487	CcSEcCtD
Mitomycin—Thrombocytopenia—Vincristine—colon cancer	0.000216	0.00485	CcSEcCtD
Mitomycin—Oedema—Irinotecan—colon cancer	0.000215	0.00483	CcSEcCtD
Mitomycin—Discomfort—Fluorouracil—colon cancer	0.000212	0.00476	CcSEcCtD
Mitomycin—Shock—Irinotecan—colon cancer	0.000211	0.00475	CcSEcCtD
Mitomycin—Thrombocytopenia—Irinotecan—colon cancer	0.00021	0.00473	CcSEcCtD
Mitomycin—Anorexia—Vincristine—colon cancer	0.00021	0.00472	CcSEcCtD
Mitomycin—Confusional state—Fluorouracil—colon cancer	0.000208	0.00466	CcSEcCtD
Mitomycin—Oedema—Fluorouracil—colon cancer	0.000206	0.00462	CcSEcCtD
Mitomycin—Anorexia—Irinotecan—colon cancer	0.000205	0.0046	CcSEcCtD
Mitomycin—Thrombocytopenia—Fluorouracil—colon cancer	0.000202	0.00453	CcSEcCtD
Mitomycin—Anorexia—Fluorouracil—colon cancer	0.000196	0.00441	CcSEcCtD
Mitomycin—Decreased appetite—Vincristine—colon cancer	0.000192	0.00431	CcSEcCtD
Mitomycin—Dyspnoea—Irinotecan—colon cancer	0.000192	0.0043	CcSEcCtD
Mitomycin—Somnolence—Irinotecan—colon cancer	0.000191	0.00429	CcSEcCtD
Mitomycin—Fatigue—Vincristine—colon cancer	0.00019	0.00427	CcSEcCtD
Mitomycin—Pain—Vincristine—colon cancer	0.000189	0.00424	CcSEcCtD
Mitomycin—Decreased appetite—Irinotecan—colon cancer	0.000187	0.0042	CcSEcCtD
Mitomycin—Fatigue—Irinotecan—colon cancer	0.000185	0.00416	CcSEcCtD
Mitomycin—Pain—Irinotecan—colon cancer	0.000184	0.00413	CcSEcCtD
Mitomycin—Dyspnoea—Fluorouracil—colon cancer	0.000183	0.00412	CcSEcCtD
Mitomycin—Somnolence—Fluorouracil—colon cancer	0.000183	0.00411	CcSEcCtD
Mitomycin—Decreased appetite—Fluorouracil—colon cancer	0.000179	0.00402	CcSEcCtD
Mitomycin—Alopecia—Capecitabine—colon cancer	0.000179	0.00402	CcSEcCtD
Mitomycin—Pancytopenia—Methotrexate—colon cancer	0.000179	0.00402	CcSEcCtD
Mitomycin—Feeling abnormal—Irinotecan—colon cancer	0.000177	0.00398	CcSEcCtD
Mitomycin—Erythema—Capecitabine—colon cancer	0.000176	0.00396	CcSEcCtD
Mitomycin—Pain—Fluorouracil—colon cancer	0.000176	0.00395	CcSEcCtD
Mitomycin—Body temperature increased—Vincristine—colon cancer	0.000174	0.00392	CcSEcCtD
Mitomycin—Body temperature increased—Irinotecan—colon cancer	0.00017	0.00382	CcSEcCtD
Mitomycin—Feeling abnormal—Fluorouracil—colon cancer	0.00017	0.00381	CcSEcCtD
Mitomycin—Drowsiness—Methotrexate—colon cancer	0.000168	0.00377	CcSEcCtD
Mitomycin—Vision blurred—Capecitabine—colon cancer	0.000166	0.00373	CcSEcCtD
Mitomycin—Renal failure—Methotrexate—colon cancer	0.000165	0.00371	CcSEcCtD
Mitomycin—Stomatitis—Methotrexate—colon cancer	0.000164	0.00367	CcSEcCtD
Mitomycin—Ill-defined disorder—Capecitabine—colon cancer	0.000164	0.00367	CcSEcCtD
Mitomycin—Anaemia—Capecitabine—colon cancer	0.000163	0.00366	CcSEcCtD
Mitomycin—Body temperature increased—Fluorouracil—colon cancer	0.000163	0.00365	CcSEcCtD
Mitomycin—Malaise—Capecitabine—colon cancer	0.000159	0.00357	CcSEcCtD
Mitomycin—Asthenia—Vincristine—colon cancer	0.000158	0.00356	CcSEcCtD
Mitomycin—Syncope—Capecitabine—colon cancer	0.000158	0.00355	CcSEcCtD
Mitomycin—Leukopenia—Capecitabine—colon cancer	0.000158	0.00354	CcSEcCtD
Mitomycin—Loss of consciousness—Capecitabine—colon cancer	0.000155	0.00348	CcSEcCtD
Mitomycin—Asthenia—Irinotecan—colon cancer	0.000154	0.00346	CcSEcCtD
Mitomycin—Cough—Capecitabine—colon cancer	0.000154	0.00345	CcSEcCtD
Mitomycin—Hypertension—Capecitabine—colon cancer	0.000152	0.00342	CcSEcCtD
Mitomycin—Diarrhoea—Vincristine—colon cancer	0.000151	0.00339	CcSEcCtD
Mitomycin—Discomfort—Capecitabine—colon cancer	0.000148	0.00333	CcSEcCtD
Mitomycin—Diarrhoea—Irinotecan—colon cancer	0.000147	0.0033	CcSEcCtD
Mitomycin—Dizziness—Vincristine—colon cancer	0.000146	0.00328	CcSEcCtD
Mitomycin—Confusional state—Capecitabine—colon cancer	0.000145	0.00326	CcSEcCtD
Mitomycin—Oedema—Capecitabine—colon cancer	0.000144	0.00323	CcSEcCtD
Mitomycin—Dizziness—Irinotecan—colon cancer	0.000142	0.00319	CcSEcCtD
Mitomycin—Shock—Capecitabine—colon cancer	0.000141	0.00318	CcSEcCtD
Mitomycin—Diarrhoea—Fluorouracil—colon cancer	0.000141	0.00316	CcSEcCtD
Mitomycin—Thrombocytopenia—Capecitabine—colon cancer	0.000141	0.00316	CcSEcCtD
Mitomycin—Vomiting—Vincristine—colon cancer	0.00014	0.00315	CcSEcCtD
Mitomycin—Rash—Vincristine—colon cancer	0.000139	0.00312	CcSEcCtD
Mitomycin—Dermatitis—Vincristine—colon cancer	0.000139	0.00312	CcSEcCtD
Mitomycin—Headache—Vincristine—colon cancer	0.000138	0.0031	CcSEcCtD
Mitomycin—Anorexia—Capecitabine—colon cancer	0.000137	0.00308	CcSEcCtD
Mitomycin—Vomiting—Irinotecan—colon cancer	0.000137	0.00307	CcSEcCtD
Mitomycin—Dizziness—Fluorouracil—colon cancer	0.000136	0.00306	CcSEcCtD
Mitomycin—Rash—Irinotecan—colon cancer	0.000135	0.00304	CcSEcCtD
Mitomycin—Dermatitis—Irinotecan—colon cancer	0.000135	0.00304	CcSEcCtD
Mitomycin—Headache—Irinotecan—colon cancer	0.000135	0.00302	CcSEcCtD
Mitomycin—Alopecia—Methotrexate—colon cancer	0.000133	0.00299	CcSEcCtD
Mitomycin—Erythema—Methotrexate—colon cancer	0.000131	0.00295	CcSEcCtD
Mitomycin—Nausea—Vincristine—colon cancer	0.000131	0.00294	CcSEcCtD
Mitomycin—Vomiting—Fluorouracil—colon cancer	0.000131	0.00294	CcSEcCtD
Mitomycin—Rash—Fluorouracil—colon cancer	0.00013	0.00291	CcSEcCtD
Mitomycin—Dermatitis—Fluorouracil—colon cancer	0.00013	0.00291	CcSEcCtD
Mitomycin—Headache—Fluorouracil—colon cancer	0.000129	0.0029	CcSEcCtD
Mitomycin—Dyspnoea—Capecitabine—colon cancer	0.000128	0.00288	CcSEcCtD
Mitomycin—Nausea—Irinotecan—colon cancer	0.000128	0.00287	CcSEcCtD
Mitomycin—Decreased appetite—Capecitabine—colon cancer	0.000125	0.00281	CcSEcCtD
Mitomycin—Fatigue—Capecitabine—colon cancer	0.000124	0.00278	CcSEcCtD
Mitomycin—Vision blurred—Methotrexate—colon cancer	0.000124	0.00278	CcSEcCtD
Mitomycin—Pain—Capecitabine—colon cancer	0.000123	0.00276	CcSEcCtD
Mitomycin—Nausea—Fluorouracil—colon cancer	0.000122	0.00275	CcSEcCtD
Mitomycin—Ill-defined disorder—Methotrexate—colon cancer	0.000122	0.00273	CcSEcCtD
Mitomycin—Anaemia—Methotrexate—colon cancer	0.000121	0.00272	CcSEcCtD
Mitomycin—Feeling abnormal—Capecitabine—colon cancer	0.000119	0.00266	CcSEcCtD
Mitomycin—Malaise—Methotrexate—colon cancer	0.000118	0.00266	CcSEcCtD
Mitomycin—Leukopenia—Methotrexate—colon cancer	0.000117	0.00264	CcSEcCtD
Mitomycin—Cough—Methotrexate—colon cancer	0.000114	0.00257	CcSEcCtD
Mitomycin—Body temperature increased—Capecitabine—colon cancer	0.000114	0.00255	CcSEcCtD
Mitomycin—Discomfort—Methotrexate—colon cancer	0.00011	0.00248	CcSEcCtD
Mitomycin—Confusional state—Methotrexate—colon cancer	0.000108	0.00242	CcSEcCtD
Mitomycin—Thrombocytopenia—Methotrexate—colon cancer	0.000105	0.00235	CcSEcCtD
Mitomycin—Asthenia—Capecitabine—colon cancer	0.000103	0.00232	CcSEcCtD
Mitomycin—Anorexia—Methotrexate—colon cancer	0.000102	0.00229	CcSEcCtD
Mitomycin—Diarrhoea—Capecitabine—colon cancer	9.84e-05	0.00221	CcSEcCtD
Mitomycin—Dyspnoea—Methotrexate—colon cancer	9.55e-05	0.00214	CcSEcCtD
Mitomycin—Somnolence—Methotrexate—colon cancer	9.52e-05	0.00214	CcSEcCtD
Mitomycin—Dizziness—Capecitabine—colon cancer	9.51e-05	0.00214	CcSEcCtD
Mitomycin—Decreased appetite—Methotrexate—colon cancer	9.31e-05	0.00209	CcSEcCtD
Mitomycin—Fatigue—Methotrexate—colon cancer	9.23e-05	0.00207	CcSEcCtD
Mitomycin—Pain—Methotrexate—colon cancer	9.16e-05	0.00206	CcSEcCtD
Mitomycin—Vomiting—Capecitabine—colon cancer	9.14e-05	0.00205	CcSEcCtD
Mitomycin—Rash—Capecitabine—colon cancer	9.07e-05	0.00204	CcSEcCtD
Mitomycin—Dermatitis—Capecitabine—colon cancer	9.06e-05	0.00203	CcSEcCtD
Mitomycin—Headache—Capecitabine—colon cancer	9.01e-05	0.00202	CcSEcCtD
Mitomycin—Feeling abnormal—Methotrexate—colon cancer	8.82e-05	0.00198	CcSEcCtD
Mitomycin—Nausea—Capecitabine—colon cancer	8.54e-05	0.00192	CcSEcCtD
Mitomycin—Body temperature increased—Methotrexate—colon cancer	8.46e-05	0.0019	CcSEcCtD
Mitomycin—Asthenia—Methotrexate—colon cancer	7.68e-05	0.00173	CcSEcCtD
Mitomycin—Diarrhoea—Methotrexate—colon cancer	7.33e-05	0.00165	CcSEcCtD
Mitomycin—Dizziness—Methotrexate—colon cancer	7.08e-05	0.00159	CcSEcCtD
Mitomycin—Vomiting—Methotrexate—colon cancer	6.81e-05	0.00153	CcSEcCtD
Mitomycin—Rash—Methotrexate—colon cancer	6.75e-05	0.00152	CcSEcCtD
Mitomycin—Dermatitis—Methotrexate—colon cancer	6.74e-05	0.00151	CcSEcCtD
Mitomycin—Headache—Methotrexate—colon cancer	6.71e-05	0.00151	CcSEcCtD
Mitomycin—Nausea—Methotrexate—colon cancer	6.36e-05	0.00143	CcSEcCtD
